B

Beijing Luzhu Biotechnology Co Ltd
HKEX:2480

Watchlist Manager
Beijing Luzhu Biotechnology Co Ltd
HKEX:2480
Watchlist
Price: 23.06 HKD 0.09% Market Closed
Market Cap: 4.6B HKD

Intrinsic Value

The intrinsic value of one Beijing Luzhu Biotechnology Co Ltd stock under the Base Case scenario is 33.96 HKD. Compared to the current market price of 23.06 HKD, Beijing Luzhu Biotechnology Co Ltd is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
33.96 HKD
Undervaluation 32%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
Beijing Luzhu Biotechnology Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Beijing Luzhu Biotechnology Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Beijing Luzhu Biotechnology Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Beijing Luzhu Biotechnology Co Ltd.

Explain Valuation
Compare Beijing Luzhu Biotechnology Co Ltd to

Fundamental Analysis

Beijing Luzhu Biotechnology Co Ltd
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Beijing Luzhu Biotechnology Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Beijing Luzhu Biotechnology Co Ltd

Balance Sheet Decomposition
Beijing Luzhu Biotechnology Co Ltd

Current Assets 461.4m
Cash & Short-Term Investments 441.4m
Other Current Assets 20m
Non-Current Assets 613.6m
Long-Term Investments 1m
PP&E 599.9m
Intangibles 8.6m
Other Non-Current Assets 4.1m
Current Liabilities 97.6m
Accrued Liabilities 3.7m
Other Current Liabilities 94m
Non-Current Liabilities 238.3m
Long-Term Debt 208.8m
Other Non-Current Liabilities 29.5m
Efficiency

Free Cash Flow Analysis
Beijing Luzhu Biotechnology Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Beijing Luzhu Biotechnology Co Ltd

Revenue
0 CNY
Operating Expenses
-136.8m CNY
Operating Income
-136.8m CNY
Other Expenses
894k CNY
Net Income
-135.9m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Beijing Luzhu Biotechnology Co Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Negative ROE
26/100
Profitability
Score

Beijing Luzhu Biotechnology Co Ltd's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Beijing Luzhu Biotechnology Co Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
68/100
Solvency
Score

Beijing Luzhu Biotechnology Co Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Beijing Luzhu Biotechnology Co Ltd

Wall Street analysts forecast Beijing Luzhu Biotechnology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beijing Luzhu Biotechnology Co Ltd is 31.62 HKD with a low forecast of 31.31 HKD and a high forecast of 32.55 HKD.

Lowest
Price Target
31.31 HKD
36% Upside
Average
Price Target
31.62 HKD
37% Upside
Highest
Price Target
32.55 HKD
41% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Beijing Luzhu Biotechnology Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Beijing Luzhu Biotechnology Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Beijing Luzhu Biotechnology Co Ltd stock?

The intrinsic value of one Beijing Luzhu Biotechnology Co Ltd stock under the Base Case scenario is 33.96 HKD.

Is Beijing Luzhu Biotechnology Co Ltd stock undervalued or overvalued?

Compared to the current market price of 23.06 HKD, Beijing Luzhu Biotechnology Co Ltd is Undervalued by 32%.

Back to Top